Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill US regulators on Monday gave the green light to a pill version of the blockbuster ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss medications in the U.S. The once-daily tablet offers a needle-free ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company’s original version of ...

FDA approves Novo Nordisk's weight-loss pill Novo aims to regain market share from Eli Lilly Pill broadens potential patient pool The pill is 25 milligrams of semaglutide, the same active ingredient ...

Many people love arts and crafts, and for good reason. A study published by Frontiers in Public Health says that engaging in these projects leads to significant mental health benefits. But with art ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Sophie Okolo Before my brain tumor diagnosis, I didn’t give a second thought ...

A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...